What are the 2022-2023 PharmaPendium content statistics?

The content release includes the following updates:

8 new drugs in PharmaPendium

• Capivasertib
• Efbemalenograstim Alfa
• Fruquintinib
• Nirogacestat Hydrobromide
• Repotrectinib
• Sitagliptin; Metformin Hydrochloride
• Taurolidine; Heparin Sodium
• Vonoprazan Fumarate

FDA Approval Documents:

• 224 new FDA Approval Documents
• 2,920 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 176 new FDA Advisory Committee Documents
• 3,964 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,136,545 pages of FDA Approval documents (Including FDA Classic Collection)
• 153,389 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,925 drugs with data in PharmaPendium
• 2,471,778 extracted safety data lines
• 2,347,648 extracted PK data lines
• 620,866 extracted ME data lines
• 3,987,017 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,438,356 FAERS (post-marketing) reports
• 19,092 documents / 411,698 pages of EMA Approval documents
• 21,797 documents / 825,423 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Anthrax Vaccine Adsorbed, Adjuvanted
• Prothrombin Complex Concentrate, Human-Lans
• Tislelizumab

FDA Approval Documents:

• 332 new FDA Approval Documents
• 4,939 new pages of FDA Approval Documents

EMA Documents:

• 69 new EMA documents
• 2,755 new pages of EMA Documents

Extracted PK data observations:

• 5,139 new extracted PK data lines

Extracted Safety data observations:

• 4,849 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,600 new ME extracted data lines

Published Toxicity Database:

• 706 new safety records

The new totals for PharmaPendium are:

• 3,133,625 pages of FDA Approval documents (Including FDA Classic Collection)
• 153,165 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,917 drugs with data in PharmaPendium
• 2,471,778 extracted safety data lines
• 2,347,658 extracted PK data lines
• 619,871 extracted ME data lines
• 3,987,017 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,438,357 FAERS (post-marketing) reports
• 19,092 documents / 411,698 pages of EMA Approval documents
• 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

9 new drugs in PharmaPendium

• Clindamycin Phosphate; Adapalene; Benzoyl Peroxide
• Etrasimod
• Gepirone Hydrochloride
• Nedosiran Sodium
• Sitagliptin
• Technetium Tc-99m Labeled Carbon
• Toripalimab
• Vamorolone
• Zilucoplan

FDA Approval Documents:

• 347 new FDA Approval Documents
• 6,007 new pages of FDA Approval Documents

FAERS:

• 405,174 new FAERS reports (2023_Q3)

The new totals for PharmaPendium are:

• 3,128,686 pages of FDA Approval documents (Including FDA Classic Collection)
• 152,833 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,914 drugs with data in PharmaPendium
• 2,466,223 extracted safety data lines
• 2,342,519 extracted PK data lines
• 618,271 extracted ME data lines
• 3,987,017 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,438,357 FAERS (post-marketing) reports
• 19,023 documents / 408,943 pages of EMA Approval documents
• 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

 1 new drug in PharmaPendium

• Gefapixant Citrate

FDA Approval Documents:

• 401 new FDA Approval Documents
• 5,439 new pages of FDA Approval Documents

EMA Documents:

• 101 new EMA documents
• 620 updated EMA documents
• 3,151 new pages of EMA Documents

Extracted PK data observations:

• 5,433 new extracted PK data lines

Extracted Safety data observations:

• 10,345 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,153 new ME extracted data lines

Published Toxicity Database:

• 498 new safety records

Efficacy Database:

• 28,128 new extracted data lines

The new totals for PharmaPendium are:

• 3,122,679 pages of FDA Approval documents (Including FDA Classic Collection)
• 152,486 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,905 drugs with data in PharmaPendium
• 2,466,223 extracted safety data lines
• 2,342,519 extracted PK data lines
• 618,266 extracted ME data lines
• 3,987,017 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,183 FAERS (post-marketing) reports
• 19,023 documents / 408,943 pages of EMA Approval documents
• 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

3 new drugs in PharmaPendium

• Elranatamab
• Momelotinib Dihydrochloride
• Motixafortide Acetate

FDA Approval Documents:

• 534 new FDA Approval Documents
• 6,245 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 85 new FDA Advisory Committee Documents
• 5,000 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,117,240 pages of FDA Approval documents (Including FDA Classic Collection)
• 152,085 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,904 drugs with data in PharmaPendium
• 2,455,380 extracted safety data lines
• 2,337,086 extracted PK data lines
• 614,113 extracted ME data lines
• 3,958,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,183 FAERS (post-marketing) reports
• 18,922 documents / 405,792 pages of EMA Approval documents
• 21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

FDA Approval Documents:

• 327 new FDA Approval Documents
• 4,376 new pages of FDA Approval Documents

EMA Documents:

• 51 new EMA documents
• 2,632 new pages of EMA Documents

Extracted PK data observations:

• 4,503 new extracted PK data lines

Extracted Safety data observations:

• 4,787 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,007 new ME extracted data lines

Published Toxicity Database:

• 472 new safety records

The new totals for PharmaPendium are:

• 3,110,995 pages of FDA Approval documents (Including FDA Classic Collection)
• 151,551 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,901 drugs with data in PharmaPendium
• 2,455,513 extracted safety data lines
• 2,337,086 extracted PK data lines
• 614,113 extracted ME data lines
• 3,958,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,183 FAERS (post-marketing) reports
• 18,922 documents / 405,792 pages of EMA Approval documents
• 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

7 new drugs in PharmaPendium

• Avacincaptad Pegol Sodium
• Delandistrogene Moxeparvovec
• Donislecel
• Palovarotene
• Pozelimab
• Talquetamab
• Zuranolone

FDA Approval Documents:

• 206 new FDA Approval Documents
• 2,827 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,106,619 pages of FDA Approval documents (Including FDA Classic Collection)
• 151,224 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,901 drugs with data in PharmaPendium
• 2,450,254 extracted safety data lines
• 2,332,583 extracted PK data lines
• 613,106 extracted ME data lines
• 3,958,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,183 FAERS (post-marketing) reports
• 18,871 documents / 403,160 pages of EMA Approval documents
• 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Sitagliptin Fumarate; Metformin Hydrochloride

FDA Approval Documents:

• 391 new FDA Approval Documents
• 5,780 new pages of FDA Approval Documents

EMA Documents:

• 112 new EMA documents
• 632 updated EMA documents
• 4,213 new pages of EMA Documents

Extracted PK data observations:

• 6,354 new extracted PK data lines

Extracted Safety data observations:

• 10,992 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,863 new ME extracted data lines

Published Toxicity Database:

• 605 new safety records

Efficacy Database:

• 47,288 new extracted data lines

The new totals for PharmaPendium are:

• 3,103,792 pages of FDA Approval documents (Including FDA Classic Collection)
• 151,018 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,894 drugs with data in PharmaPendium
• 2,450,254 extracted safety data lines
• 2,332,583 extracted PK data lines
• 613,135 extracted ME data lines
• 3,958,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,183 FAERS (post-marketing) reports
• 18,871 documents / 403,160 pages of EMA Approval documents
• 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

Last updated on August 23, 2023

The content release includes the following updates:

4 new drugs in PharmaPendium

• Beremagene Geperpavec
• Cantharidin
• Lotilaner
• Respiratory Syncytial Virus Vaccine

FDA Approval Documents:

• 515 new FDA Approval Documents
• 5,799 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 184 new FDA Advisory Committee Documents
• 4,661 new pages of FDA Advisory Committee Documents

FAERS:

• 416,330 new FAERS reports (2023_Q2)

The new totals for PharmaPendium are:

• 3,098,012 pages of FDA Approval documents (Including FDA Classic Collection)
• 150,627 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,893 drugs with data in PharmaPendium
• 2,438,657 extracted safety data lines
• 2,326,229 extracted PK data lines
• 608,272 extracted ME data lines
• 3,911,601 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,033,176 FAERS (post-marketing) reports
• 18,759 documents / 398,947 pages of EMA Approval documents
• 21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Mirikizumab

FDA Approval Documents:

• 472 new FDA Approval Documents
• 6,090 new pages of FDA Approval Documents

EMA Documents:

• 87 new EMA documents
• 4,039 new pages of EMA Documents

Extracted PK data observations:

• 2,569 new extracted PK data lines

Extracted Safety data observations:

• 4,287 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,627 new ME extracted data lines

Published Toxicity Database:

• 717 new safety records

The new totals for PharmaPendium are:

• 3,092,213 pages of FDA Approval documents (Including FDA Classic Collection)
• 150,112 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,889 drugs with data in PharmaPendium
• 2,438,657 extracted safety data lines
• 2,326,229 extracted PK data lines
• 608,272 extracted ME data lines
• 3,911,601 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,846 FAERS (post-marketing) reports
• 18,759 documents / 398,947 pages of EMA Approval documents
• 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Efgartigimod Alfa; Hyaluronidase
• Glofitamab
• Niraparib Tosylate Monohydrate; Abiraterone Acetate
• Polyethylene Glycol 3350; Sodium, Magnesium Sulfate; Potassium, Sodium Chloride
• Ritlecitinib Tosylate
• Rozanolixizumab

FDA Approval Documents:

• 339 new FDA Approval Documents
• 4,948 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,086,123 pages of FDA Approval documents (Including FDA Classic Collection)
• 149,640 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,888 drugs with data in PharmaPendium
• 2,433,653 extracted safety data lines
• 2,323,660 extracted PK data lines
• 606,945 extracted ME data lines
• 3,911,601 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,846 FAERS (post-marketing) reports
• 18,672 documents / 394,908 pages of EMA Approval documents
• 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Cipaglucosidase Alfa
• Vadadustat

FDA Approval Documents:

• 463 new FDA Approval Documents
• 6,367 new pages of FDA Approval Documents

EMA Documents:

• 106 new EMA documents
• 715 updated EMA documents
• 4,177 new pages of EMA Documents

Extracted PK data observations:

• 6,261 new extracted PK data lines

Extracted Safety data observations:

• 9,114 new extracted safety data lines

Metabolizing Enzymes Database:

• 5,797 new ME extracted data lines

Published Toxicity Database:

• 530 new safety records

Efficacy Database:

• 27,094 new extracted data lines

The new totals for PharmaPendium are:

• 3,081,175 pages of FDA Approval documents (Including FDA Classic Collection)
• 149,301 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,882 drugs with data in PharmaPendium
• 2,433,653 extracted safety data lines
• 2,323,713 extracted PK data lines
• 606,659 extracted ME data lines
• 3,911,601 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,627 FAERS (post-marketing) reports
• 18,672 documents / 394,908 pages of EMA Approval documents
• 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

9 new drugs in PharmaPendium

• Epcoritamab
• Fecal Microbiota Spores, Live
• Fezolinetant
• Flotufolastat F-18
• Omidubicel
• Pegunigalsidase Alfa
• Perfluorohexyloctane
• Sulbactam; Durlobactam
• Tropicamide; Phenylephrine Hydrochloride

FDA Approval Documents:

• 410 new FDA Approval Documents
• 5,192 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 255 new FDA Advisory Committee Documents
• 4,770 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,074,808 pages of FDA Approval documents (Including FDA Classic Collection)
• 148,838 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,880 drugs with data in PharmaPendium
• 2,424,009 extracted safety data lines
• 2,317,452 extracted PK data lines
• 600,862 extracted ME data lines
• 3,884,507 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,625 FAERS (post-marketing) reports
• 18,566 documents / 390,731 pages of EMA Approval documents
• 21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 153 new FDA Approval Documents
• 2,320 new pages of FDA Approval Documents

EMA Documents:

• 68 new EMA documents
• 2,575 new pages of EMA Documents

Extracted PK data observations:

• 3,856 new extracted PK data lines

Extracted Safety data observations:

• 4,114 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,909 new ME extracted data lines

Published Toxicity Database:

• 410 new safety records

The new totals for PharmaPendium are:

• 3,069,616 pages of FDA Approval documents (Including FDA Classic Collection)
• 148,428 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,871 drugs with data in PharmaPendium
• 2,424,009 extracted safety data lines
• 2,317,452 extracted PK data lines
• 600,862 extracted ME data lines
• 3,884,507 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,625 FAERS (post-marketing) reports
• 18,566 documents / 390,731 pages of EMA Approval documents
• 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Respiratory Syncytial Virus Vaccine, Adjuvanted
• Tofersen

FDA Approval Documents:

• 327 new FDA Approval Documents
• 4,827 new pages of FDA Approval Documents

FAERS:

• 426,722 new FAERS reports

The new totals for PharmaPendium are:

• 3,067,296 pages of FDA Approval documents (Including FDA Classic Collection)
• 148,275 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,871 drugs with data in PharmaPendium
• 2,419,485 extracted safety data lines
• 2,313,596 extracted PK data lines
• 598,953 extracted ME data lines
• 3,884,507 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,616,625 FAERS (post-marketing) reports
• 18,498 documents / 388,156 pages of EMA Approval documents
• 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• COVID-19 Vaccine (Hipra)

FDA Approval Documents:

• 283 new FDA Approval Documents
• 4,037 new pages of FDA Approval Documents
• 106 new EMA documents
• 548 updated EMA documents
• 3,364 new pages of EMA Documents

Extracted PK data observations:

• 7,071 new extracted PK data lines

Extracted Safety data observations:

• 8,539 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,731 new ME extracted data lines

Published Toxicity Database:

• 547 new safety records

Efficacy Database:

• 23,879 new extracted data lines

The new totals for PharmaPendium are:

• 3,062,469 pages of FDA Approval documents (Including FDA Classic Collection)
• 147,948 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,869 drugs with data in PharmaPendium
• 2,419,485 extracted safety data lines
• 2,313,596 extracted PK data lines
• 598,957 extracted ME data lines
• 3,884,507 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,903 FAERS (post-marketing) reports
• 18,498 documents / 388,156 pages of EMA Approval documents
• 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

8 new drugs in PharmaPendium

• Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl
• Leniolisib Phosphate
• Nadofaragene Firadenovec
• Omaveloxolone
• Retifanlimab
• Rezafungin
• Trofinetide
• Zavegepant Hydrochloride

FDA Approval Documents:

• 303 new FDA Approval Documents
• 3,744 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 114 new FDA Advisory Committee Documents
• 3,190 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,058,432 pages of FDA Approval documents (Including FDA Classic Collection)
• 147,665 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,868 drugs with data in PharmaPendium
• 2,410,399 extracted safety data lines
• 2,306,525 extracted PK data lines
• 594,226 extracted ME data lines
• 3,860,628 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,903 FAERS (post-marketing) reports
• 18,392 documents / 384,792 pages of EMA Approval documents
• 21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 393 new FDA Approval Documents
• 4,966 new pages of FDA Approval Documents

EMA Documents:

• 63 new EMA documents
• 3,443 new pages of EMA Documents

Extracted PK data observations:

• 4,256 new extracted PK data lines 

Extracted Safety data observations:

• 4,490 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,726 new ME extracted data lines

Published Toxicity Database:

• 600 new safety records

The new totals for PharmaPendium are:

• 3,054,688 pages of FDA Approval documents (Including FDA Classic Collection)
• 147,362 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,860 drugs with data in PharmaPendium
• 2,410,399 extracted safety data lines
• 2,306,525 extracted PK data lines
• 594,226 extracted ME data lines
• 3,860,628 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,903 FAERS (post-marketing) reports
• 18,392 documents / 384,792 pages of EMA Approval documents
• 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Daprodustat
• Deutetrabenzine
• Neostigmine Methylsulfate; Glycopyrrolate
• Phenobarbital Sodium
• Pirtobrutinib
• Sparsentan

FDA Approval Documents:

• 413 new FDA Approval Documents
• 5,759 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,049,722 pages of FDA Approval documents (Including FDA Classic Collection)
• 146,969 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,860 drugs with data in PharmaPendium
• 2,405,309 extracted safety data lines
• 2,302,269 extracted PK data lines
• 590,500 extracted ME data lines
• 3,860,628 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,903 FAERS (post-marketing) reports
• 18,329 documents / 381,349 pages of EMA Approval documents
• 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Tabelecleucel

FDA Approval Documents:

• 327 new FDA Approval Documents
• 4,947 new pages of FDA Approval Documents

EMA Documents:

• 79 new EMA documents
• 689 updated EMA documents
• 1,858 new pages of EMA Documents

Extracted PK data observations:

• 4,699 new extracted PK data lines

Extracted Safety data observations:

• 13,102 new extracted safety data lines

Metabolizing Enzymes Database:

• 5,051 new ME extracted data lines

Published Toxicity Database:

• 385 new safety records

Efficacy Database:

• 46,863 new extracted data lines

The new totals for PharmaPendium are:

• 3,043,963 pages of FDA Approval documents (Including FDA Classic Collection)
• 146,556 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,854 drugs with data in PharmaPendium
• 2,405,309 extracted safety data lines
• 2,302,269 extracted PK data lines
• 590,520 extracted ME data lines
• 3,860,628 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,868 FAERS (post-marketing) reports
• 18,329 documents / 381,349 pages of EMA Approval documents
• 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

7 new drugs in PharmaPendium

• Albuterol; Budesonide
• Anacaulase
• Bexagliflozin
• Elacestrant
• Lecanemab
• Ublituximab
• Xenon Xe-129 Hyperpolarized

FDA Approval Documents:

• 223 new FDA Approval Documents
• 3,533 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 90 new FDA Advisory Committee Documents
• 3,178 new pages of FDA Advisory Committee Documents

FAERS:

• 484,816 new FAERS reports (2022_Q4)

The new totals for PharmaPendium are:

• 3,039,016 pages of FDA Approval documents (Including FDA Classic Collection)
• 146,229 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,853 drugs with data in PharmaPendium
• 2,391,822 extracted safety data lines
• 2,297,570 extracted PK data lines
• 585,469 extracted ME data lines
• 3,813,765 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 20,189,868 FAERS (post-marketing) reports
• 18,250 documents / 379,491 pages of EMA Approval documents
• 20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 241 new FDA Approval Documents
• 3,582 new pages of FDA Approval Documents

EMA Documents:

• 143 new EMA documents
• 6,849 new pages of EMA Documents

Extracted PK data observations:

• 4,902 new extracted PK data lines

Extracted Safety data observations:

• 4,444 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,182 new ME extracted data lines

Published Toxicity Database:

• 433 new safety records

The new totals for PharmaPendium are:

• 3,035,483 pages of FDA Approval documents (Including FDA Classic Collection)
• 146,006 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,846 drugs with data in PharmaPendium
• 2,391,822 extracted safety data lines
• 2,297,661 extracted PK data lines
• 585,596 extracted ME data lines
• 3,813,765 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 18,250 documents / 379,491 pages of EMA Approval documents
• 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Adagrasib
• Etranacogene Dezaparvovec
• Fecal Microbiota, Live
• Olutasidenib

FDA Approval Documents:

• 416 new FDA Approval Documents
• 4,496 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,031,901 pages of FDA Approval documents (Including FDA Classic Collection)
• 145,765 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,846 drugs with data in PharmaPendium
• 2,386,945 extracted safety data lines
• 2,292,759 extracted PK data lines
• 582,414 extracted ME data lines
• 3,813,765 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 18,107 documents / 372,642 pages of EMA Approval documents
• 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• COVID-19 Vaccine (Vidprevtyn Beta)
• Nirsevimab

FDA Approval Documents:

• 568 new FDA Approval Documents
• 6,671 new pages of FDA Approval Documents

EMA Documents:

• 101 new EMA documents
• 629 updated EMA documents
• 3,290 new pages of EMA Documents

Extracted PK data observations:

• 5,898 new extracted PK data lines

Extracted Safety data observations:

• 16,452 new extracted safety data lines

Metabolizing Enzymes Database:

• 8,272 new ME extracted data lines

Published Toxicity Database:

• 524 new safety records

Efficacy Database:

• 35,670 new extracted data lines

The new totals for PharmaPendium are:

• 3,027,405 pages of FDA Approval documents (Including FDA Classic Collection)
• 145,349 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,842 drugs with data in PharmaPendium
• 2,386,945 extracted safety data lines
• 2,292,780 extracted PK data lines
• 582,536 extracted ME data lines
• 3,813,765 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 18,107 documents / 372,642 pages of EMA Approval documents
• 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Mirvetuximab Soravtansine
• Teplizumab

FDA Approval Documents:

• 199 new FDA Approval Documents
• 2,994 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 143 new FDA Advisory Committee Documents
• 4,398 new pages of FDA Advisory Committee Documents 

The new totals for PharmaPendium are:

• 3,020,734 pages of FDA Approval documents (Including FDA Classic Collection)
• 144,781 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,840 drugs with data in PharmaPendium
• 2,369,969 extracted safety data lines
• 2,286,882 extracted PK data lines
• 574,264 extracted ME data lines
• 3,778,095 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 18,006 documents / 369,352 pages of EMA Approval documents
• 20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 213 new FDA Approval Documents
• 2,535 new pages of FDA Approval Documents

EMA Documents:

• 81 new EMA documents
• 2,293 new pages of EMA Documents

Extracted PK data observations:

• 3,497 new extracted PK data lines

Extracted Safety data observations:

• 6,917 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,113 new ME extracted data lines

Published Toxicity Database:

• 503 new safety records

The new totals for PharmaPendium are:

• 3,017,740 pages of FDA Approval documents (Including FDA Classic Collection)
• 144,582 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,838 drugs with data in PharmaPendium
• 2,369,770 extracted safety data lines
• 2,286,518 extracted PK data lines
• 574,264 extracted ME data lines
• 3,776,644 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 18,006 documents / 369,317 pages of EMA Approval documents
• 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Futibatinib
• Teclistamab
• Tremelimumab

FDA Approval Documents:

• 295 new FDA Approval Documents
• 4,418 new pages of FDA Approval Documents

FAERS:

• 443,265 new FAERS reports (2022_Q3)

The new totals for PharmaPendium are:

• 3,015,205 pages of FDA Approval documents (Including FDA Classic Collection)
• 144,369 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,838 drugs with data in PharmaPendium
• 2,362,350 extracted safety data lines
• 2,283,021 extracted PK data lines
• 573,151 extracted ME data lines
• 3,776,644 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,705,052 FAERS (post-marketing) reports
• 17,925 documents / 367,024 pages of EMA Approval documents
• 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates: 

1 new drug in PharmaPendium 

• Valoctocogene Roxaparvovec 

FDA Approval Documents: 

• 480 new FDA Approval Documents
• 8,407 new pages of FDA Approval Documents 

EMA Documents: 

• 100 new EMA documents
• 768 updated EMA documents
• 3,344 new pages of EMA Documents 

Extracted PK data observations: 

• 4,966 new extracted PK data lines 

Extracted Safety data observations: 

• 9,907 new extracted safety data lines 

Metabolizing Enzymes Database: 

• 7,500 new ME extracted data lines 

Published Toxicity Database: 

• 265 new safety records

 Efficacy Database: 

• 27,875 new extracted data lines

The new totals for PharmaPendium are:

• 3,010,787 pages of FDA Approval documents (Including FDA Classic Collection)
• 144,074 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,835 drugs with data in PharmaPendium
• 2,362,350 extracted safety data lines
• 2,283,021 extracted PK data lines
• 573,133 extracted ME data lines
• 3,776,644 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,787 FAERS (post-marketing) reports
• 17,925 documents / 367,024 pages of EMA Approval documents
• 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Daxibotulinumtoxina
• Deucravacitinib
• Eflapegrastim
• Gadopiclenol
• Omidenepag Isopropyl
• Sodium Phenylbutyrate; Sodium Taurursodiol

 FDA Approval Documents: 

• 316 new FDA Approval Documents
• 4,548 new pages of FDA Approval Documents 

FDA Advisory Committee Documents: 

• 101 new FDA Advisory Committee Documents
• 3,297 new pages of FDA Advisory Committee Documents 

The new totals for PharmaPendium are:

• 3,002,380 pages of FDA Approval documents (Including FDA Classic Collection)
• 143,594 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,834 drugs with data in PharmaPendium
• 2,352,178 extracted safety data lines
• 2,278,055 extracted PK data lines
• 565,633 extracted ME data lines
• 3,748,769 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,787 FAERS (post-marketing) reports
• 17,825 documents / 363,680 pages of EMA Approval documents
• 20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Eladocagene Exuparvovec
• Lenacapavir Sodium
• Sitagliptin Hydrochloride; Metformin Hydrochloride

 FDA Approval Documents:

• 228 new FDA Approval Documents
• 2,919 new pages of FDA Approval Documents

 EMA Documents: 

• 98 new EMA documents
• 2,927 new pages of EMA Documents 

Extracted PK data observations: 

• 5,348 new extracted PK data lines 

Extracted Safety data observations: 

• 4,066 new extracted safety data lines 

Metabolizing Enzymes Database: 

• 2,880 new ME extracted data lines 

Published Toxicity Database: 

• 784 new safety records 

The new totals for PharmaPendium are:

• 2,997,832 pages of FDA Approval documents (Including FDA Classic Collection)
• 143,278 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,828 drugs with data in PharmaPendium
• 2,352,121 extracted safety data lines
• 2,278,055 extracted PK data lines
• 565,633 extracted ME data lines
• 3,748,769 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,787 FAERS (post-marketing) reports
• 17,825 documents / 363,680 pages of EMA Approval documents
• 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Bupropion Hydrochloride; Dextromethorphan Hydrobromide
• Spesolimab

FDA Approval Documents:

• 175 new FDA Approval Documents
• 1,982 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 2,994,913 pages of FDA Approval documents (Including FDA Classic Collection)
• 143,050 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,825 drugs with data in PharmaPendium
• 2,347,271 extracted safety data lines
• 2,272,707 extracted PK data lines
• 562,753 extracted ME data lines
• 3,748,769 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,787 FAERS (post-marketing) reports
• 17,727 documents / 360,753 pages of EMA Approval documents
• 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

7 new drugs in PharmaPendium

• Betula Pendula Roth; Betula Pubescens Ehrh.
• COVID-19 Vaccine (Valneva)
• Leuprorelin Mesilate
• Linzagolix Choline
• Mosunetuzumab
• Olipudase Alfa
• Sitagliptin Hydrochloride Monohydrate

FDA Approval Documents:

• 232 new FDA Approval Documents
• 3,856 new pages of FDA Approval Documents

EMA Documents:

• 175 new EMA documents
• 472 updated EMA documents
• 3,952 new pages of EMA Documents

Extracted PK data observations:

• 9,784 new extracted PK data lines

Extracted Safety data observations:

• 7,559 new extracted safety data lines

Metabolizing Enzymes Database:

• 5,746 new ME extracted data lines

Published Toxicity Database:

• 533 new safety records

Efficacy Database:

• 37,519 new extracted data lines

The new totals for PharmaPendium are:

• 2,992,931 pages of FDA Approval documents (Including FDA Classic Collection)
• 142,875 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,823 drugs with data in PharmaPendium
• 2,343,722 extracted safety data lines
• 2,272,723 extracted PK data lines
• 562,753 extracted ME data lines
• 3,748,769 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,787 FAERS (post-marketing) reports
• 17,727 documents / 360,753 pages of EMA Approval documents
• 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Levoketoconazole
• Venlafaxine Besylate Monohydrate

FDA Approval Documents:

• 371 new FDA Approval Documents
• 4,368 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 178 new FDA Advisory Committee Documents
• 5,958 new pages of FDA Advisory Committee Documents

FAERS:

• 432,610 new FAERS reports (2022_Q2)

The new totals for PharmaPendium are:

• 2,989,075 pages of FDA Approval documents (Including FDA Classic Collection)
• 142,643 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,816 drugs with data in PharmaPendium
• 2,335,631 extracted safety data lines
• 2,262,939 extracted PK data lines
• 557,007 extracted ME data lines
• 3,711,250 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 19,261,732 FAERS (post-marketing) reports
• 17,552 documents / 356,801 pages of EMA Approval documents
• 20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 669 new FDA Approval Documents
• 7,691 new pages of FDA Approval Documents

EMA Documents:

• 96 new EMA documents
• 2,027 new pages of EMA Documents

Extracted PK data observations:

• 5,500 new extracted PK data lines

Extracted Safety data observations:

• 4,299 new extracted safety data lines

Metabolizing Enzymes Database:

• 763 new ME extracted data lines

Published Toxicity Database:

• 457 new safety records

The new totals for PharmaPendium are:

• 2,984,707 pages of FDA Approval documents (Including FDA Classic Collection)
• 142,272 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,814 drugs with data in PharmaPendium
• 2,335,631 extracted safety data lines
• 2,262,939 extracted PK data lines
• 557,007 extracted ME data lines
• 3,711,250 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 18,829,122 FAERS (post-marketing) reports
• 17,552 documents / 356,801 pages of EMA Approval documents
• 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drugs in PharmaPendium

• Vutrisiran

FDA Approval Documents:

• 417 new FDA Approval Documents
• 6,016 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 2,977,016 pages of FDA Approval documents (Including FDA Classic Collection)
• 141,603 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,814 drugs with data in PharmaPendium
• 2,330,875 extracted safety data lines
• 2,257,439 extracted PK data lines
• 556,244 extracted ME data lines
• 3,711,250 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 18,829,122 FAERS (post-marketing) reports
• 17,456 documents / 354,774 pages of EMA Approval documents
• 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 703 new FDA Approval Documents
• 7,391 new pages of FDA Approval Documents

EMA Documents:

• 86 new EMA documents
• 639 updated EMA documents
• 2,416 new pages of EMA Documents

Extracted PK data observations:

• 20,954 new extracted PK data lines

Extracted Safety data observations:

• 8,116 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,810 new ME extracted data lines

Published Toxicity Database:

• 754 new safety records

Efficacy Database:

• 31,206 new extracted data lines

The new totals for PharmaPendium are:

• 2,971,000 pages of FDA Approval documents (Including FDA Classic Collection)
• 141,186 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,813 drugs with data in PharmaPendium
• 2,331,161 extracted safety data lines
• 2,257,497 extracted PK data lines
• 556,144 extracted ME data lines
• 3,711,276 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 18,829,122 FAERS (post-marketing) reports
• 17,458 documents / 354,874 pages of EMA Approval documents
• 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

8 new drugs in PharmaPendium

• Amoxicillin; Clarithromycin; Vonoprazan
• Amoxicillin; Vonoprazan
• Lisocabtagene Maraleucel
• Mavacamten
• Oteseconazole
• Tapinarof
• Tirzepatide
• Tixagevimab; Cilgavimab

FDA Approval Documents:

• 879 new FDA Approval Documents
• 11,068 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 76 new FDA Advisory Committee Documents
• 2,324 new pages of FDA Advisory Committee Documents

EMA Documents:

• 111 new EMA documents
• 3,190 new pages of EMA Documents

New Meyler’s Documents and Safety data observations:

• 1,436 New Meyler’s documents
• 6,295 pages of New Meyler’s Documents
• 105,517 New Meyler’s extracted safety data lines

Extracted PK data observations:

• 2,863 new extracted PK data lines

Extracted Safety data observations:

• 4,537 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,151 new ME extracted data lines

Published Toxicity Database:

• 726 new safety records

The new totals for PharmaPendium are:

• 2,963,609 pages of FDA Approval documents (Including FDA Classic Collection)
• 140,483 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,813 drugs with data in PharmaPendium
• 2,354,793 extracted safety data lines
• 2,236,543 extracted PK data lines
• 552,334 extracted ME data lines
• 3,680,070 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 18,829,122 FAERS (post-marketing) reports
• 17,372 documents / 352,458 pages of EMA Approval documents
• 20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 420 new FDA Approval Documents
• 6,115 new pages of FDA Approval Documents

FAERS:

• 457,110 new FAERS reports (2022_Q1)

The new totals for PharmaPendium are:

• 2,952,541 pages of FDA Approval documents (Including FDA Classic Collection)
• 139,604 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,805 drugs with data in PharmaPendium
• 2,317,045 extracted safety data lines
• 2,233,680 extracted PK data lines
• 551,183 extracted ME data lines
• 3,681,160 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 18,828,706 FAERS (post-marketing) reports
• 17,261 documents / 349,268 pages of EMA Approval documents
• 20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents